CIM Enviro

Activities: Manufacturing Analysis

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Addressing the pharmaceutical industry’s energy blind spots

Paul Walsh, General Manager at CIM, explores the major energy consumption challenges facing the UK’s pharmaceutical manufacturing and life science industry … and how innovative approaches to data analysis can stimulate further decarbonisation
Design & Build

Taking on the life science industry’s big energy costs

Life science manufacturing is notoriously energy intensive, often because of the necessary use of cleanrooms. However, Cillian Casey, Head of Operations and Customer Success, EMEA, at CIM, argues that the solution lies in an HVAC energy reduction strategy that can target non-validated areas and provide actionable insight for high-consumption validated ones
Subscribe now